High-Risk Ccus Is Clinically Indistinguishable from Low-Risk Myelodysplastic Syndromes/Neoplasms

Zhuoer Xie; Zena Komrokji; Michael Otterstatter; Ling Zhang; Lynn C. Moscinski; Najla H. Al Ali; David Sallman; Jeffrey E Lancet; Amy E. DeZern; Mikkael A. Sekeres; Rami S. Komrokji; Nancy Gillis; Eric Padron

doi:10.1182/blood-2024-203837

Back

High-Risk Ccus Is Clinically Indistinguishable from Low-Risk Myelodysplastic Syndromes/Neoplasms

Journal article

Peer reviewed

High-Risk Ccus Is Clinically Indistinguishable from Low-Risk Myelodysplastic Syndromes/Neoplasms

Zhuoer Xie, Zena Komrokji, Michael Otterstatter, Ling Zhang, Lynn C. Moscinski, Najla H. Al Ali, David Sallman, Jeffrey E Lancet, Amy E. DeZern, Mikkael A. Sekeres, …

Blood, Vol.144(Supplement 1), pp.354-354

2024-11-05

DOI: https://doi.org/10.1182/blood-2024-203837

Appears in Miller School of Medicine - Latest Publications

Metrics

2 Record Views

Details

Title: High-Risk Ccus Is Clinically Indistinguishable from Low-Risk Myelodysplastic Syndromes/Neoplasms
Creators: Zhuoer Xie - Moffitt Cancer Center
Zena Komrokji - Moffitt Cancer Center
Michael Otterstatter - Emmes
Ling Zhang - Moffitt Cancer Center
Lynn C. Moscinski - Moffitt Cancer Center
Najla H. Al Ali - Moffitt Cancer Center
David Sallman - Moffitt Cancer Center
Jeffrey E Lancet - Moffitt Cancer Center
Amy E. DeZern - Sidney Kimmel Comprehensive Cancer Center
Mikkael A. Sekeres - Sylvester Comprehensive Cancer Center
Rami S. Komrokji - Moffitt Cancer Center
Nancy Gillis - Moffitt Cancer Center
Eric Padron - Moffitt Cancer Center
Publication Details: Blood, Vol.144(Supplement 1), pp.354-354
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032518122902976